European Hand Sanitizer Market Expected to Reach $9.4 Billion by 2027.
Growing at a CAGR of 38.4% during 2019–2027.
The European hand sanitizer market was valued at US$ 641.7 million in 2018 and is expected to...
Antibiotic-Resistant Super Gonorrhea (CDC).
"We are currently down to one last recommended and effective class of antibiotics, cephalosporins, to treat this common infection."
"Gonorrhea is skilled at outsmarting the...
Is Overuse of Antibiotics on Farms Worsening the Spread of Antibiotic-Resistant Bacteria? (CBSNews)
Public health officials investigating a drug-resistant salmonella outbreak in 2015 still don't know the exact source after a pork-industry lobbying group on behalf of...
Drug Resistance Could Kill 10M People per year by 2050, Experts say (Axios).
Infectious disease experts tell Axios they agree with a dire scenario painted in the UN report posted earlier this week saying that, if nothing changes, antimicrobial...
CDC’s Worst-Case Coronavirus Model: 214 Million Infected, 1.7 Million Dead (Intelligencer)
A recent CDC projection estimated that the U.S. coronavirus epidemic could infect between 160 million and 214 million people over a period of more...
Exosomes, Extracellular Vesicles, and the CoronaVirus.
Uploading a Series of Articles on Extracellular Vesicles, Including Potential Effects on the CoronaVirus and ARDS.
Article #1: the basics in non-scientific terms from Larry...
Adding Corbis Pharma (CRBP) $5.55 to Watch List.
Running Clinical Trials Full Steam With $46 Million Banked in Late February.
Not thinly, but lightly traded. Ready, locked and loaded.
All of the common...
Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.
A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one of its...
Athersys (ATHX) Overview and Due Diligence links (Reddit)
I've (Dalek on Reddit) compiled a list of links that might be useful if you are disorganized like myself. If you are a newcomer...
Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
- Novellus's patented mRNA-based cell-reprogramming...
Latest article
GeoVax (GOVX) Monkeypox (MPOX) PowerPoint.
In a recent press release, GeoVax shared progress on their MPOX Vaccine and published a PowerPoint related to the their planned upcoming MonkeyPox related...
Rick Rule Symposium – Conference Cheat Sheet
Natural Resource Investing Symposium - Presenter Guide
We've attended hundreds and hundreds of Investment Conferences (Barclay, JP Morgan, LD Micro, Piper Sandler, Roth, VRIC) since...
GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!
What an Entertaining Week!
..and it's only Thursday.
LIVE QUOTE
(MAY 18TH)
(MAY 21ST)
So Where Does That Leave us Today?
Yes, it was a pleasant surprise to see GeoVax...
